Medpace Holdings Inc. said one of its shareholders was looking to sell 3 million shares of the company.
Investment funds affiliated with Cinven Capital Management (V) General Partner Ltd. will sell the stocks in a secondary offering. The company will not receive any proceeds from the transaction.
Morgan Stanley is acting as the sole book runner in the offering.
Cinven Ltd. held 13,399,997 shares of the Cincinnati-based contract research organization as of May 7, representing 35.85% of the company, according to S&P Capital IQ data. The shares had a market value of $582.9 million.
